he controversial patent deal between Allergan (AGN) and a Native American tribe is now engulfing the pharmaceutical industry trade group.

In a pointed letter, U.S. Sen. Claire McCaskill (D-Mo.) told the Pharmaceutical Research & Manufacturers of America that it should review whether Allergan’s sales of lucrative patents is in keeping with the organization’s boastful mission to “promote innovation and discourage predatory pricing practices and anticompetitive conduct.”

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • These deals are turning out to be the life blood of the tribes. According to published sources there has been a drastic fall off in gaming revenues to the upstate NY Mohawks due to both a depressed economy and the weakness of the Canadian dollar. Looks like they’re in tough shape and the revenue from these patent deals looks to fill a needed revenue stream.

Recommended Stories

Pharmaceutical production
Drug Pricing

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.